Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines-Reference-Cited by-同舟云学术

Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines

Published:2020-11 Issue: Volume:233 Page:105003
ISSN:0009-3084
Container-title:Chemistry and Physics of Lipids
language:en
Short-container-title:Chemistry and Physics of Lipids

Author:

Ahmed Mohammed Muqtader^ORCID,Fatima Farhat,Anwer Md. Khalid,Aldawsari Mohammed F.,Alsaidan Yasser Saud M.,Alfaiz Suliman Abdulaziz,Haque Anzarul,AZ Alanazi,Alhazzani Khalid^ORCID

Funder

Prince Sattam Bin Abdulaziz University

Publisher

Elsevier BV

Subject

Cell Biology,Organic Chemistry,Molecular Biology,Biochemistry

Reference38 articles.

1. Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines;Alberg;Chest,2013

2. Temperature dependent solubility studies of brigatinib in some pure solvents useful in dosage form development;Alshahrani;Acta Poloniae Pharmaceutica - Drug Research,2019

3. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats;Ansari;Drug Deliv.,2016

4. Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity;Attama;Colloids Surf. A Physicochem. Eng. Asp.,2008

5. Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs;Bayón-Cordero;Nanomaterials,2019

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies;Journal of Drug Delivery Science and Technology;2024-09

2. Recent nanotechnological aspects and molecular targeting strategies for lung cancer therapy;Journal of Nanoparticle Research;2024-05

3. Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer;International Journal of Pharmaceutics;2024-01

4. Specific Application of Lipid-Based Nanoparticular Drug Delivery Systems for Cancer Therapy;Handbook of Cancer and Immunology;2023-11-13

5. Chondroitin/Lactoferrin-dual functionalized pterostilbene-solid lipid nanoparticles as targeted breast cancer therapy;International Journal of Pharmaceutics;2023-07